Polyomavirus BK-Specific CD4+ T Cells Response to VP1 Stimulation in Kidney Transplant Recipients

Nasrin Noshadi,Ramin Yaghobi,Afsoon Afshari,Mohsen Forouzanfar,Saeede Soleimanian
DOI: https://doi.org/10.18502/ijaai.v23i3.15637
2024-06-16
Iranian Journal of Allergy Asthma and Immunology
Abstract:Reactivation of Polyomavirus BK (BKPyV) is related to reduction of T cells response in kidney transplant recipients (KTRs). Here, we examined the differentiation of CD4 + T cells subsets in response to BKPyV KTRs, using the BKPyV VP1 (viral capsid protein 1) as a stimulator. We categorized our samples into three distinct groups: 1. Reactive BKPyV (BKPyV + ), 2. non-reactive (BKPyV - ) KTRs and 3. Healthy controls. BKPyV - KTRs and healthy controls stimulated with VP1 and BKPyV+ unstimulated with VP1. The human CD4 + T cells was stimulation with VP1-Ag. The proportion of CD4 + T lymphocytes and their various subsets, including naive T cells, central memory T cells (TCM), and effector memory T cells (TEM) was measured using flowcytometry. BKPyV - KTRs VP1 + indicated significantly lower TCM CD4 + T cells in contrast with both BKPyV + KTRs VP1 - , and healthy controls VP1 + . This indicates that VP1 stimulation may reduce TCM cell levels in these patients. The percentage of TEM in the BKPyV - KTRs VP1 + group was significantly less prevalent than the BKPyV + KTRs VP1 - group. The percentage of TEM cells in BKPyV + KTRs VP1 - was significantly lower than the healthy controls VP1 + . Stimulation with VP1 protein significantly increased the frequency of cytotoxic CD4 + T cells in BKPyV - KTRs VP1 + compared to BKPyV + KTRs VP1 - . The present research has shown that the VP1 stimulation of CD4 + T cells can induce cytotoxic CD4 + T cells responses that may help overcome BKPyV infection in KTRs. However, VP1 stimulation may also differentially affect TCM and TEM CD4 + T cells subsets.
immunology,allergy
What problem does this paper attempt to address?